Ahrens Investment Partners’s Ocular Therapeutix OCUL Stock Holding History

Ahrens Investment Partners’s Portfolio OCUL Stock Details OCUL Fund Activity

Upgrade to unlock

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	$42.2K	Buy
2022 Q3	–	Sell
2022 Q2	$32K	Buy
2022 Q1	$37K	Hold
2021 Q4	$52K	Buy
2020 Q1	–	Sell
2019 Q4	$41K	Buy